WHY IS PREVENTION IMPORTANT?
|
|
- Jared Baker
- 5 years ago
- Views:
Transcription
1 A GUIDE TO
2 TRUST THE POWER OF PREVENTION < 2 > WHY IS PREVENTION IMPORTANT? Hereditary angioedema (HAE) symptoms can range in severity. Some attacks may be mild or temporarily disabling, but others can become more dangerous due to throat swelling. Severe swelling of the throat can make breathing difficult and result in a life-threatening emergency. Prevention can be a good option to help reduce the frequency and severity of attacks. It is important to note that treatment plans, when discussed, should be individualized to your needs. Guidelines recommend talking to your doctor about the frequency and severity of your HAE attacks when planning your treatment. Remember, the location of an attack may have an impact on severity, eg, an airway attack is likely to be considered severe. CINRYZE (C1 esterase inhibitor [human]) is approved by the FDA to help prevent swelling and/or painful attacks in teenagers and adults with HAE. THINK ABOUT WHY YOU HAVE CHOSEN CINRYZE TO PROACTIVELY TREAT YOUR HAE
3 TRUST THE POWER OF PREVENTION < 3 > Dariela, a real HAE patient TRUST THE POWER OF PREVENTION WITH CINRYZE Indication CINRYZE (C1 esterase inhibitor [human]) is an injectable prescription medicine that is used to help prevent swelling and/or painful attacks in teenagers and adults with Hereditary Angioedema (HAE). You should not use CINRYZE if you have had life-threatening immediate hypersensitivity reactions, including anaphylaxis to the product. Please see additional on adjacent pages. Please see the Full Prescribing Information available at
4 TRUST THE POWER OF PREVENTION < 4 > HOW DOES CINRYZE WORK? HAE is caused by an insufficient amount of or defective C1 esterase inhibitor, a protein in the blood that helps to prevent swelling experienced during HAE attacks. UNTREATED PERSON WITH HAE People with HAE have an insufficient amount of or defective C1 esterase inhibitor, which contributes to a cascade of events in the body. This leads to increased production of bradykinin, a protein that causes your vessels to leak fluid into the tissues. Fluid moves out through the leaky blood vessel walls and builds up between the tissue cells underneath the skin, which results in localized swelling. Red blood cell Tissue cell Blood vessel wall C1 esterase inhibitor Bradykinin Fluid leakage Tell your healthcare provider about all of your medical conditions, including if you: have an indwelling catheter/access device in one of your veins. have a history of blood clots, heart disease, or stroke. are taking birth control pills or androgens. are pregnant or planning to become pregnant. It is not known if CINRYZE (C1 esterase inhibitor [human]) can harm your unborn baby. are breastfeeding or plan to breastfeed. It is not known if CINRYZE passes into your milk and if it can harm your baby. Please see additional on adjacent pages. Please see the Full Prescribing Information available at
5 CINRYZE (C1 esterase inhibitor [human]), which is administered by intravenous (IV) infusion, increases plasma levels of C1 inhibitor activity. PERSON WITH HAE RECEIVING CINRYZE CINRYZE increases your body s supply of functional C1 esterase inhibitor, which may reduce the production of bradykinin and control the swelling associated with HAE. Allergic reactions may occur with CINRYZE. Call your healthcare provider or get emergency support services right away if you have any of the following symptoms: wheezing difficulty breathing chest tightness turning blue (look at lips and gums) fast heartbeat swelling of the face faintness rash hives
6 TRUST THE POWER OF PREVENTION < 6 > CINRYZE HAS BEEN PROVEN EFFECTIVE The safety and effectiveness of CINRYZE (C1 esterase inhibitor [human]) were evaluated in a 24-week clinical trial of 22 patients. Patients in the study were diagnosed with HAE and had a history of at least two attacks per month. Patients were divided into two groups: one group received CINRYZE for the first 12 weeks and switched to placebo for the last 12 weeks; the other group received placebo for the first 12 weeks and switched to CINRYZE for the last 12 weeks. The most common side effects observed in the clinical trial were rash, headache, nausea, and vomiting. No patients discontinued treatment because of an adverse reaction. HOW WAS EFFECTIVENESS MEASURED? The main measure was to determine the number of attacks experienced by each patient when taking CINRYZE compared with the number of attacks experienced by each patient when taking placebo. Serious blood clots may occur with CINRYZE. Call your healthcare provider or get emergency support services right away if you have any of the following symptoms: pain and/or swelling of an arm or leg with warmth over the affected area discoloration of an arm or leg unexplained shortness of breath chest pain or discomfort that worsens on deep breathing unexplained rapid heart rate numbness or weakness on one side of the body Please see additional on adjacent pages. Please see the Full Prescribing Information available at
7 CINRYZE HELPED PREVENT ATTACKS IN MOST PATIENTS While on CINRYZE (C1 esterase inhibitor [human]), the majority of patients had fewer attacks The response to CINRYZE varied Of the 22 patients, 4 had no attacks and 2 had more attacks NUMBER OF ATTACKS Mean (average) Min Max CINRYZE (22 PATIENTS) 6.1* 0 17 PLACEBO (22 PATIENTS) *P< vs placebo Because CINRYZE is made from human blood, it may carry a risk of transmitting infectious agents, e.g., viruses and, theoretically, the Creutzfeldt-Jakob disease (CJD) agent. The most common side effects seen with CINRYZE were headache, nausea, rash, and vomiting. These are not all the possible side effects of CINRYZE. Tell your healthcare provider about any side effect that bothers you or that does not go away. You are encouraged to report negative side effects of prescription drugs to the FDA. Visit or call FDA You can also report side effects to Shire Medical Information at
8 TRUST THE POWER OF PREVENTION < 8 > Since having my first CINRYZE infusion...i am happy to say that the frequency of my attacks has been reduced. Jeanie, a real HAE patient
9 CINRYZE HELPED TO REDUCE THE SEVERITY AND DURATION OF ATTACKS During treatment with CINRYZE (C1 esterase inhibitor [human]), compared to placebo, patients experienced: Decrease in the average duration of attacks Attacks lasted 2.1 days while taking CINRYZE vs. 3.4 days while taking placebo (p<0.01) Fewer days of swelling 66% reduction in days of swelling (p<0.01) Decrease in the average severity of attacks On a 3-point scale (1=Mild, 2=Moderate, 3=Severe), attacks while taking CINRYZE were ranked as less severe than were attacks while taking placebo (1.3 vs. 1.9, p<0.01) REMEMBER THAT PREVENTION WITH CINRYZE CAN HELP REDUCE THE BURDEN OF YOUR HAE ATTACKS It can be helpful to have a treatment plan in case of emergency. Discuss your options with your healthcare provider. Indication CINRYZE (C1 esterase inhibitor [human]) is an injectable prescription medicine that is used to help prevent swelling and/or painful attacks in teenagers and adults with Hereditary Angioedema (HAE). You should not use CINRYZE if you have had life-threatening immediate hypersensitivity reactions, including anaphylaxis to the product. Please see additional on adjacent pages. Please see the Full Prescribing Information available at
10 TRUST THE POWER OF PREVENTION < 10 > HOW IS CINRYZE MADE? CINRYZE (C1 esterase inhibitor [human]) is made from purified human blood that is collected from US plasma donors at US-licensed collection centers. Products made from human blood may contain infectious agents. CINRYZE goes through a complex purification process. The process is designed to help protect you by reducing the risk of transmitting infectious disease. The specific steps to minimize the risk of transmitting an infectious agent include careful donor screening, testing for the presence of viruses, pasteurization and nanofiltration. Because CINRYZE is made from human blood, it may carry a risk of transmitting infectious agents, e.g., viruses and, theoretically, the Creutzfeldt-Jakob disease (CJD) agent. The most common side effects seen with CINRYZE were headache, nausea, rash, and vomiting. These are not all the possible side effects of CINRYZE. Tell your healthcare provider about any side effect that bothers you or that does not go away. You are encouraged to report negative side effects of prescription drugs to the FDA. Visit or call FDA You can also report side effects to Shire Medical Information at Please see additional on adjacent pages. Please see the Full Prescribing Information available at
11 After weighing the benefits and possible side effects with my specialist, I was convinced that CINRYZE might help. Scott, a real HAE patient
12 TRUST THE POWER OF PREVENTION < 12 > HOW IS CINRYZE ADMINISTERED? The administration of CINRYZE (C1 esterase inhibitor [human]) requires a needle to be placed in a vein in your arm. CINRYZE should be prepared and administered at room temperature, and it takes about 10 minutes to complete the injection. DOSING OF CINRYZE DOSE 1000 U intravenous (2) 500 U vials of CINRYZE + (2) 5 ml vials of Sterile Water for Injection, USP DOSING REGIMEN Single dose can be administered every 3 or 4 days INFUSION RATE 1 ml/min (10 minutes) UNDERSTAND THAT MISSING A DOSE OF CINRYZE CAN RESULT IN BREAKTHROUGH ATTACKS If you miss a dose of CINRYZE, infuse as soon as you remember and call your healthcare provider to adjust your treatment schedule as needed. Allergic reactions may occur with CINRYZE. Call your healthcare provider or get emergency support services right away if you have any of the following symptoms: wheezing difficulty breathing chest tightness turning blue (look at lips and gums) fast heartbeat swelling of the face faintness rash hives Please see additional on adjacent pages. Please see the Full Prescribing Information available at
13 FLEXIBLE ADMINISTRATION OPTIONS There are many options to consider when administering CINRYZE (C1 esterase inhibitor [human]). Talk to your healthcare provider about which option is best for you and your lifestyle. Administration by a healthcare provider at an infusion center, a doctor s office, or in your home STORING CINRYZE CINRYZE should be stored at 2 C to 25 C (36 F to 77 F) CINRYZE should be protected from light Once CINRYZE is prepared, it must be used within 3 hours Administration by a trained family member or caregiver Self-administration Path to Independence is a training and support program designed to help teach patients, family members, or caregivers how to self-administer or administer CINRYZE. For more information, contact your OnePath Case Manager at STAY ON TRACK WITH THE TREATMENT SCHEDULE THAT YOU AND YOUR DOCTOR AGREED ON Patients should only self-administer after being trained by a healthcare provider. Serious blood clots may occur with CINRYZE. Call your healthcare provider or get emergency support services right away if you have any of the following symptoms: pain and/or swelling of an arm or leg with warmth over the affected area discoloration of an arm or leg unexplained shortness of breath chest pain or discomfort that worsens on deep breathing unexplained rapid heart rate numbness or weakness on one side of the body
14 TRUST THE POWER OF PREVENTION < 14 > ADDITIONAL RESOURCES The US Hereditary Angioedema Association (HAEA) is another great resource for people living with HAE and for their families. Visit the HAEA website at to learn about the wide variety of services offered by the organization. You, Me & HAE, a mentor program, can pair you with a mentor who also has HAE and is currently on therapy with CINRYZE (C1 esterase inhibitor [human]). Contact your OnePath Case Manager to request a mentor. TAKE ADVANTAGE OF PERSONALIZED PRODUCT SERVICES WITH ONEPATH TO MAINTAIN YOUR INDEPENDENCE The most common side effects seen with CINRYZE were headache, nausea, rash, and vomiting. These are not all the possible side effects of CINRYZE. Tell your healthcare provider about any side effect that bothers you or that does not go away. You are encouraged to report negative side effects of prescription drugs to the FDA. Visit or call FDA You can also report side effects to Shire Medical Information at Please see additional on adjacent pages. Please see the Full Prescribing Information available at
15 QUESTIONS? Your OnePath Case Manager can help by: Answering questions about CINRYZE (C1 esterase inhibitor [human]) Helping you gain access to therapy Navigating insurance coverage Finding infusion centers while you are traveling Providing ongoing support and more! Call your OnePath Case Manager at for more information. Through the OnePath product support service, I have my own Case Manager who has been a great help. He always keeps me informed. Dariela, a real HAE patient Indication CINRYZE (C1 esterase inhibitor [human]) is an injectable prescription medicine that is used to help prevent swelling and/or painful attacks in teenagers and adults with Hereditary Angioedema (HAE). You should not use CINRYZE if you have had life-threatening immediate hypersensitivity reactions, including anaphylaxis to the product.
16 TRUST THE POWER OF PREVENTION WITH CINRYZE THINK ABOUT WHY YOU HAVE CHOSEN CINRYZE (C1 ESTERASE INHIBITOR [HUMAN]) TO PROACTIVELY TREAT YOUR HAE REMEMBER THAT PREVENTION WITH CINRYZE CAN HELP REDUCE THE BURDEN OF YOUR HAE ATTACKS UNDERSTAND THAT MISSING A DOSE OF CINRYZE CAN RESULT IN BREAKTHROUGH ATTACKS STAY ON TRACK WITH THE TREATMENT SCHEDULE THAT YOU AND YOUR DOCTOR AGREED ON TAKE ADVANTAGE OF PERSONALIZED PRODUCT SERVICES WITH ONEPATH TO MAINTAIN YOUR INDEPENDENCE FOR MORE INFORMATION, VISIT Please see the inside and the Full Prescribing Information available at CINRYZE, OnePath, Path to Independence, and the associated logos are either registered trademarks or trademarks of Shire or its affiliates Shire. All rights reserved. S /2016
STAYING ON TRACK WITH CINRYZE THERAPY
YOUR GUIDE TO STAYING ON TRACK WITH CINRYZE THERAPY Indication CINRYZE (C1 esterase inhibitor [human]) is an injectable prescription medicine that is used to help prevent swelling and/or painful attacks
More informationPREPARATION AND SELF-ADMINISTRATION INSTRUCTIONS FOR PATIENTS
PREPARATION AND SELF-ADMINISTRATION INSTRUCTIONS FOR PATIENTS Hereditary Angioedema Jenny, a real HAE patient TAKE CONTROL OF YOUR HEREDITARY ANGIOEDEMA (HAE) TREATMENT WITH SELF-ADMINISTRATION Choosing
More informationPREPARATION AND SELF-ADMINISTRATION INSTRUCTIONS FOR PATIENTS
PREPARATION AND SELF-ADMINISTRATION INSTRUCTIONS FOR PATIENTS Hereditary Angioedema TAKE CONTROL OF HEREDITARY ANGIOEDEMA (HAE) TREATMENT WITH FLEXIBLE ADMINISTRATION Choosing to treat with CINRYZE (C1
More informationRECONSTITUTION AND ADMINISTRATION INSTRUCTIONS FOR HEALTHCARE PROFESSIONALS. Hereditary Angioedema
RECONSTITUTION AND ADMINISTRATION INSTRUCTIONS FOR HEALTHCARE PROFESSIONALS Hereditary Angioedema TRUST PROVEN PREVENTION WITH CINRYZE Whether your patients are new to treatment or are continuing their
More informationRECONSTITUTION AND ADMINISTRATION INSTRUCTIONS FOR HEALTHCARE PROFESSIONALS
RECONSTITUTION AND ADMINISTRATION INSTRUCTIONS FOR HEALTHCARE PROFESSIONALS TRUST THE POWER OF PREVENTION WITH CINRYZE Whether your patients are new to treatment or are continuing their journey, remind
More informationplan prepare progress
plan prepare progress Hereditary Angioedema (HAE) Treatment Plan and Therapy Journal Plan, prepare, and personalize an effective treatment plan for your HAE attacks Share your progress with your healthcare
More informationReconstitution and Administration Instructions for Healthcare Professionals.
Reconstitution and Administration Instructions for Healthcare Professionals. Indication CINRYZE (C1 esterase inhibitor [human]) is indicated for routine prophylaxis against angioedema attacks in adolescent
More informationCinryze. Cinryze (C1 esterase inhibitor [human]) Description
Federal Employee Program 1310 G Street, N.W. Washington, D.C. 20005 202.942.1000 Fax 202.942.1125 5.85.05 Subject: Cinryze Page: 1 of 5 Last Review Date: September 20, 2018 Cinryze Description Cinryze
More informationCSL Behring PACKAGE LEAFLET: INFORMATION FOR THE USER
CSL Behring PACKAGE LEAFLET: INFORMATION FOR THE USER Berinert 500 IU Powder and solvent for solution for injection / infusion Berinert 1500 IU Powder and solvent for solution for injection Human C1-esterase
More informationTREATMENT GUIDE. Your treatment. Your questions answered.
TREATMENT GUIDE Your treatment. Your questions answered. INDICATIONS: Kineret is a prescription medicine called an interleukin-1 receptor antagonist (IL-1ra) used to: Reduce the signs and symptoms, and
More informationSubject: Hereditary Angioedema Drug Therapy
09-J1000-08 Original Effective Date: 07/15/09 Reviewed: 01/09/18 Revised: 02/15/19 Subject: Hereditary Angioedema Drug Therapy THIS MEDICAL COVERAGE GUIDELINE IS NOT AN AUTHORIZATION, CERTIFICATION, EXPLANATION
More informationThe legally binding text is the original French version TRANSPARENCY COMMITTEE OPINION. 20 June 2012
The legally binding text is the original French version TRANSPARENCY COMMITTEE OPINION 20 June 2012 CINRYZE 500 units, 2100 IU, powder and solvent for solution for injection B/2 bottles (CIP code: 218
More informationPanzyga Administration Guide
Immune Human Normal Globulin Immunoglobulin Intravenous (Human) (IVIg) Octapharma s new Intravenous Immunoglobulin (IVIG) Panzyga Administration Guide An educational service tool provided by Octapharma
More informationSee Important Reminder at the end of this policy for important regulatory and legal information.
Clinical Policy: (Human, Recombinant) Reference Number: CP.CPA.76 Effective Date: 11.16.16 Last Review Date: 08.17 Line of Business: Medicaid Medi-Cal Revision Log See Important Reminder at the end of
More informationPrescribing BERINERT: An Instructional Guide
Prescribing BERINERT: An Instructional Guide BERINERT is a plasma-derived C1 Esterase Inhibitor (Human) indicated for the treatment of acute abdominal, facial, or laryngeal hereditary angioedema (HAE)
More informationNatural Hair Transplant Medical Center, Inc Dove Street, Suite #250, Newport Beach, CA Phone
Natural Hair Transplant Medical Center, Inc. 1000 Dove Street, Suite #250, Newport Beach, CA 92660 Phone-949-622-6969 Finasteride (PROPECIA ) Acknowledgement Finasteride is an oral medication, manufactured
More informationBerinert [C1 Esterase Inhibitor (Human)] For intravenous use. Freeze-Dried Powder for Reconstitution. Initial U.S. Approval: 2009
HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use Berinert safely and effectively. See full prescribing information for Berinert. Berinert [C1 Esterase
More informationPACKAGE LEAFLET: INFORMATION FOR THE USER. Exembol Multidose 100 mg/ml concentrate for solution for infusion. Argatroban Monohydrate
PACKAGE LEAFLET: INFORMATION FOR THE USER Exembol Multidose 100 mg/ml concentrate for solution for infusion Argatroban Monohydrate Read all of this leaflet carefully before you start using this medicine.
More informationPACKAGE LEAFLET: INFORMATION FOR THE USER. FINASTERIDE 1 MG FILM-COATED TABLETS (finasteride)
PACKAGE LEAFLET: INFORMATION FOR THE USER FINASTERIDE 1 MG FILM-COATED TABLETS (finasteride) Read all of this leaflet carefully before you start taking this medicine because it contains important information
More informationElements for a public summary
VI.2 VI.2.1 Elements for a public summary Overview of disease epidemiology Prostate gland enlargement is a common condition as men get older. Also called benign prostatic hyperplasia (BPH) and prostatic
More informationANNEX 1 SUMMARY OF PRODUCT CHARACTERISTICS
ANNEX 1 SUMMARY OF PRODUCT CHARACTERISTICS 1 1. NAME OF THE MEDICINAL PRODUCT Ruconest 2100 U powder for solution for injection. 2. QUALITATIVE AND QUANTITATIVE COMPOSITION One vial contains 2100 units
More informationElements for a Public Summary. Overview of disease epidemiology
VI.2 VI.2.1 Elements for a Public Summary Overview of disease epidemiology Benign prostatic hyperplasia (BPH) (an increase in size of the prostate that is not cancerous) is the most prevalent of all diseases
More informationBefore you use KINERET. When you must not use it. Do not use KINERET if you have. using a medicine known as tumour necrosis factor (TNF) antagonist.
KINERET anakinra Consumer Medicine Information What is in this leaflet This leaflet answers some common questions about KINERET. It does not contain all the available information. It does not take the
More informationBefore you use. When you must not use it
anakinra Consumer Medicine Information What is in this leaflet This leaflet answers some common questions about KINERET. It does not contain all the available information. It does not take the place of
More informationNOTES PATIENT DETAILS
NOTES PATIENT DETAILS Patient Name: Patient MRN: Department: Date of Insertion: Type of Central Line: Size of Central Line: Booklet given and explained by: Signed: CONTACT NUMBERS Hospital Telephone No:
More informationANNEX I SUMMARY OF PRODUCT CHARACTERISTICS
ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS 1 This medicinal product is subject to additional monitoring. This will allow quick identification of new safety information. Healthcare professionals are asked
More informationObjectives: Assisting with Medication, Checking vital Signs
Assisting with Medication, Checking vital Signs Duty: Assist Client with Personal Hygiene Task : A.12 Remind client to take medication A.17 Check client s temperature A.18 Check client s pulse A.19 Check
More informationFINASTERIDE (PROPECIA, PROSCAR) SIDE EFFECT & CONSENT FORM
750 West Broadway Street Suite 905 Vancouver, BC M5Z 1K1 FAX: (604) 648-9003 vancouveroffice@donovanmedical.com FINASTERIDE (PROPECIA, PROSCAR) SIDE EFFECT & CONSENT FORM What is finasteride? Finasteride
More informationGynaecomastia. Benign breast conditions information provided by Breast Cancer Care
Gynaecomastia This booklet tells you about gynaecomastia. It explains what gynaecomastia is, what causes it, how it s diagnosed and what will happen if it needs to be treated or followed up. Benign breast
More informationM0BCore Safety Profile. Pharmaceutical form(s)/strength: 5 mg SE/H/PSUR/0002/006 Date of FAR:
M0BCore Safety Profile Active substance: Finasteride Pharmaceutical form(s)/strength: 5 mg P-RMS: SE/H/PSUR/0002/006 Date of FAR: 16.05.2014 4.3 Contraindications Finasteride is not indicated for use in
More informationRUCONEST - conestat alfa injection, powder, for solution Santarus, Inc
RUCONEST - conestat alfa injection, powder, for solution Santarus, Inc. ---------- HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use RUCONEST safely
More informationFIRST AID. Study Topics. At a minimum, the following topics are to be studied for the first aid exam.
FIRST AID Study Topics At a minimum, the following topics are to be studied for the first aid exam. TOPIC Avoid getting air in stomach during rescue breathing Burns Kinds of Burns & Care Calling for Help
More informationChapter 37 (pages ): Hereditary Angioedema and Bradykinin-Mediated Angioedema Prepared by: Sarah Spriet, DO
FIT Board Review Corner May 2017 Welcome to the FIT Board Review Corner, prepared by Tammy Peng, MD, and Amar Dixit, MD, senior and junior representatives of ACAAI's Fellows-In-Training (FITs) to the Board
More informationANNEX I SUMMARY OF PRODUCT CHARACTERISTICS
ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS 1 1. NAME OF THE MEDICINAL PRODUCT Ruconest 2100 U powder for solution for injection. 2. QUALITATIVE AND QUANTITATIVE COMPOSITION One vial contains 2100 units
More informationPRODUCT INFORMATION TESTOVIRON DEPOT. (testosterone enanthate)
PRODUCT INFORMATION TESTOVIRON DEPOT (testosterone enanthate) NAME OF THE MEDICINE Testosterone enanthate is designated chemically as 17 beta-heptanoyloxy-4-androstene-3- one. The empirical formula of
More informationPACKAGE LEAFLET: INFORMATION FOR THE USER. Neophyr 225 ppm mol/mol medicinal gas, compressed
PIL p. 1/6 PACKAGE LEAFLET: INFORMATION FOR THE USER Nitric oxide 225 ppm, 450 ppm, 1000 ppm mol/mol Read all of this leaflet carefully before you start using this medicine because it contains important
More informationOXYGEN FOR ADULTS IN ACUTE CARE
PATIENT GROUP DIRECTION FOR THE ADMINISTRATION OF OXYGEN FOR ADULTS IN ACUTE CARE ALL CLINICAL DIVISIONS ADULT CARE STATEMENT The staff indicated in Staff Group may administer oxygen in the two detailed
More informationYou should wear disposable vinyl or latex gloves whenever there is risk of contact with a patient's blood or body fluids.
DISASTER MEDICAL OPERATIONS STUDY GUIDE Spurting bright red blood is most likely to be bleeding. [A] capillary [B] internal [C] venous [D] arterial (correct answer) Patient fell off his bike and injured
More informationPublic Assessment Report. Berinert. C1-Esterase-Inhibitor, human DE/H/0481/001/MR. Applicant: CSL Behring GmbH. Date of Report:
Public Assessment Report Berinert C1-Esterase-Inhibitor, human DE/H/0481/001/MR Applicant: CSL Behring GmbH Date of Report: 02.02.2009 This module reflects the scientific discussion for the approval of
More informationCounty of Santa Clara Emergency Medical Services System
County of Santa Clara Emergency Medical Services System Policy # 700-S01 Ebola Virus Prevention and Control EBOLA VIRUS PREVENTION AND CONTROL Effective: October 30, 2014 Replaces: October 8, 2014 (Version
More informationSecond Quarter 2018 Results Call Corporate Update & Financial Results. August 7, 2018
Second Quarter 2018 Results Call Corporate Update & Financial Results August 7, 2018 Forward-Looking Statements BioCryst s presentation may contain forward-looking statements, including statements regarding
More informationAndrogens and Anabolic Steroids Prior Authorization with Quantity Limit - Through Preferred Topical Androgen Agent
Androgens and Anabolic Steroids Prior Authorization with Quantity Limit - Through Preferred Topical Androgen Agent Androgens/Anabolic Steroids Prior Authorization with Quantity Limit Through Preferred
More informationCOMMUNITY RESPONSE TO MEDICAL EMERGENCIES:
COMMUNITY RESPONSE TO MEDICAL EMERGENCIES: For any on-campus emergency, dial x456 from an on campus phone or From a cell phone dial 508-494-9010. A medical emergency can occur anywhere on campus. The reaction
More informationPHYSICIANS CIRCULAR FINASTERIDE PROSCAR. Tablet 5-Alpha Reductase Inhibitor
PHYSICIANS CIRCULAR FINASTERIDE PROSCAR Tablet 5-Alpha Reductase Inhibitor FINASTERIDE (PROSCAR) a synthetic 4-azasteroid compound, is a specific inhibitor of Type II 5α-reductase, an intracellular enzyme
More informationBleeding: Chapter 22 page 650
Bleeding: Chapter 22 page 650 The Significance of Bleeding When patient have serious external blood loss it is often difficult to determine the amount of blood that is present because it may be absorbed
More informationHAE management and future perspectives
HAE management and future perspectives Marcus Maurer Allergie-Centrum-Charité Department of Dermatology and Allergy Charité - Universitätsmedizin Berlin Germany Disclosure of Significant Relationships
More informationAssisting with Insertion. Care of Intraspinal Catheters
Guidelines included: Assisting with an Insertion Care of Various types of Intraspinal s Care of the Intraspinal Infusion Monitoring Removal of the Short Term Non Assisting with Insertion INR should be
More informationPAIN RELIEF SYSTEM PATIENT GUIDELINES
PAIN RELIEF SYSTEM PATIENT GUIDELINES THIS GUIDELINE IS INTENDED TO SUPPLEMENT THE SPECIFIC INSTRUCTIONS FROM YOUR HEALTHCARE PROVIDER. Pump A SELECT-A-FLOW * Variable Rate Controller Clamp Filter Attaches
More informationControl of Bleeding. Managing Shock. Interim Training Materials G2015 G2015 Updated First Aid Topics Basic First Aid
Interim Training Materials G2015 G2015 Updated First Aid Topics Basic First Aid Control of Bleeding Blood vessels are present throughout the body. Bleeding occurs when tissues are damaged. Clot-forming
More informationIndications for Use: Caution: Note:
IV 1 2 IV This reference is to be used in conjunction with the Crit-Line IV Monitor User s Guide (P/N CL80050002). Refer to the User s Guide for a complete description of alerts, warnings, cautions, and
More informationTREATMENT AN EDUCATIONAL SERIES BROUGHT TO YOU BY GILEAD SCIENCES
PLANNING FOR TREATMENT AN EDUCATIONAL SERIES BROUGHT TO YOU BY GILEAD SCIENCES ADVANCES IN HEP C TREATMENT LEARN MORE ABOUT HEP C There s never been a better time to treat Hep C. Recent scientific advances
More informationPOWERPRESS UNIT. User Manual. Gradient Pneumatic Sequential Compressor. Neomedic
TIMER (MIN) POWERPRESS UNIT 40 70 40 80 90 10 60 100 MIN MAX PRESSURE (mmhg) User Manual Neomedic 9601 Owens mouth Ave. #8 Chatsworth, CA 91311 Toll Free: 866-990-1168 Tel: 818-998-1023 Fax: 818-998-0277
More information1001 West Broadway, Vancouver, BC V6H 4B1. Topical Finasteride
1001 West Broadway, Vancouver, BC V6H 4B1 Topical Finasteride 1 Topical finasteride is a solution containing the drug finasteride typically sold under the brand names Propecia and Proscar. The Finasteride
More informationOccupational diver medical assessment questionnaire
Occupational diver medical assessment questionnaire Occupational divers in New Zealand must undergo a full diving medical examination every five years, or as determined by the Diving Medical Consultant
More informationPatient Information for the: Humanitarian Device for use in the Control of Air Leaks
Patient Information for the: Humanitarian Device for use in the Control of Air Leaks Glossary Airway: The tubes in the lungs that pass air to and from the lung tissue. Anesthesia: Technique to make the
More informationUpdate on recent trials in the treatment of hereditary angioedema
Review: Clinical Trial Outcomes Update on recent trials in the treatment of hereditary angioedema Clin. Invest. (2011) 1(3), 439 445 Hereditary angioedema (HAE) is a rare genetic condition that manifests
More informationEXTERNAL BLEEDING Definition: This is where the blood vessels and the skin are cut and blood is escaping the body. Causes: Damage to the skin caused by trauma. Can be a laceration (clean cut), abrasion,
More informationCHAPTER 13: FIRST AID MEDICAL PROCEDURES
CHAPTER 13: FIRST AID MEDICAL PROCEDURES General Overview First aid cases include one-time treatment and subsequent observation of minor scratches, cuts, burns, splinters, and so forth, which do not ordinarily
More informationEXTREME HEAT. Extreme Heat Related Terms. Heat Wave - Prolonged period of excessive heat, often combined with excessive humidity.
Residents of southeast Louisiana are typically accustomed to dealing with warm, humid weather. But extreme and prolonged heat and humidity conditions can result in serious medical emergencies, even for
More informationComfortmax Thermax Hot/Cold Water Circulation System. Instructions for Use
Comfortmax Thermax Hot/Cold Water Circulation System Instructions for Use THIS DEVICE CAN BE COLD ENOUGH TO CAUSE SERIOUS INJURY. SERIOUS ADVERSE REACTIONS AND SAFETY HAZARDS MAY OCCUR WHEN USING THIS
More information1 out of every 5,555 of drivers dies in car accidents 1 out of every 7692 pregnant women die from complications 1 out of every 116,666 skydives ended
1 out of every 5,555 of drivers dies in car accidents 1 out of every 7692 pregnant women die from complications 1 out of every 116,666 skydives ended in a fatality in 2000 1 out of every 126,626 marathon
More informationHLTAID003 Provide first aid Summary question booklet
HLTAID003 Provide first aid Summary question booklet First aider responsibilities 1. Work Health and Safety legislation covers: (a) Only hazardous workplaces (b) Only workplaces that are isolated from
More informationANNEX I SUMMARY OF PRODUCT CHARACTERISTICS
ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS 1 1. NAME OF THE MEDICINAL PRODUCT Firazyr 30 mg solution for injection in pre-filled syringe 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Each pre-filled syringe
More informationFirst Aid Handbook. Contents
First Aid Handbook Contents Bleeding Cuts or Wounds... 2 Hands-Only CPR for Adults... 3 Thermal Burns Treatment... 4 For All Burns... 4 For First-Degree Burns (Affecting Top Layer of Skin)... 4 For Second-Degree
More informationKcentra SDS Revision Date: 06/03/2015
1. Identification 1.1. Product identifier Product Identity Alternate Names Kcentra Kcentra 1.2. Relevant identified uses of the substance or mixture and uses advised against Intended use Application Method
More informationREEFTRIP.com. Medical Questionnaire Dive Medical Recreational AS Section Abbott Street, Cairns T: E:
REEFTRIP.com 100 Abbott Street, Cairns T: 07 4037 2700 E: info@reeftrip.com Medical Questionnaire Dive Medical Recreational AS4005.1 Please complete the following Section 1 1 Surname: Given Names 2 Date
More informationVenturer Scout Unit Program Planner
Venturer Scout Unit Program Planner Theme First Aid Date Attendance Time Minutes Activity Type Activity Description Equipment 5 Ceremony Opening Parade Australian Flag Prayer Book 70 Activity Danger CPR
More informationImportant Notices. Mouthpiece. Used properly, POWERbreathe can be used safely by almost anyone without any harmful side effects.
Mouthpiece Valve lower chamber tensioner knob End Cap load calibrated spring Important Notices Used properly, POWERbreathe can be used safely by almost anyone without any harmful side effects. 1. If you
More informationHyperbaric Oxygen Therapy
What is? Hyperbaric oxygen therapy (HBO therapy) is a medical treatment that helps treat many different medical conditions. It involves breathing 100% oxygen while in a pressurized chamber. How does it
More informationPackage leaflet: Information for the user Finasteride 5 mg Film-coated Tablets Finasteride
Package leaflet: Information for the user Finasteride Read all of this leaflet carefully before you start taking this medicine because it contains important information for you. Keep this leaflet. You
More informationPackage Leaflet: Information for the patient. Sustanon 250, 250 mg/ml, solution for injection (testosterone esters)
Package Leaflet: Information for the patient Sustanon 250, 250 mg/ml, solution for injection (testosterone esters) Read all of this leaflet carefully before you start using this medicine because it contains
More informationHereditary angioedema (HAE) is a rare genetic condition
SYMPOSIUM REPORT SUPPLEMENT Hereditary Angioedema Therapy: Kallikrein Inhibition and Bradykinin Receptor Antagonism Marc Riedl, MD, MS Abstract: Current strategies for the treatment of hereditary angioedema
More informationBreathe easier. Patient guide to oxygen therapy
Breathe easier Patient guide to oxygen therapy Table of contents The facts about COPD The facts about COPD 3 Understanding oxygen therapy 4 Choices in oxygen therapy equipment You have been prescribed
More information2. Women may experience others signs/symptoms in addition to the common ones. What are the additional symptoms?
Name: Sports Medicine II Date: Block 3A Caring for Cardiac Emergencies CPR/AED for the Professional Rescuer Notes Questions/Main Ideas Notetaking Column 1. Name some signs and symptoms of a heart attack.
More information1 st Response Information Sheets. For use with the full 1 st Response course.
1 st Response Information Sheets For use with the full 1 st Response course. Aims and objectives The aim of 1 st Response is to ensure Girlguiding/Scouting members are kept as safe as possible while they
More informationOxygen Therapy. What tests can be done to determine the need for oxygen?
Oxygen Therapy Oxygen is in the air we breathe and is necessary to live. When we breathe in, oxygen enters the lungs and it goes into the blood. When the lungs cannot transfer enough oxygen into the blood,
More informationHealth Products Regulatory Authority
1 NAME OF THE VETERINARY MEDICINAL PRODUCT Myodine 25 mg/ml solution for injection for dogs and cats 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Each ml contains: Active substance: Nandrodine laurate 25
More informationFirst Aid - immediate care that is given to the victim of an injury or illness until experts can take over - Oftentimes, it s the difference between
First Aid First Aid - immediate care that is given to the victim of an injury or illness until experts can take over - Oftentimes, it s the difference between life and death or recovery vs permanent disability
More informationPackage leaflet: Information to the user. Kalinox 50 %/50 % medicinal gas, compressed. Nitrous oxide / Oxygen
Package leaflet: Information to the user Kalinox 50 %/50 % medicinal gas, compressed Nitrous oxide / Oxygen Read all of this leaflet carefully before you start using this medicine because it contains important
More informationPACKAGE LEAFLET: INFORMATION FOR THE USER. Lamisil 1 % cutaneous spray solution Terbinafine hydrochloride
The PL includes alternative texts for different legal status in different countries as follows: - Boxed texts are only applicable for OTC versions. - [Grey-shaded texts in brackets] are only applicable
More informationPERSONAL INJURY PATIENT HISTORY
PERSONAL INJURY PATIENT HISTORY Name Date Address Phone Cell Phone E-Mail For text reminders, your cell phone provider: Date of Birth: Social Security Number: Date of the accident: Time: AM PM What city
More informationProvide First Aid Theory Assessment Marking Key ASSESSOR ONLY THEORY ASSESSMENT WITH ANSWERS
Provide Theory Assessment Marking Key ASSESSOR ONLY THEORY ASSESSMENT WITH ANSWERS 1. Four ways you would recognise an emergency are: Sight, small sound and unusual behaviour. Sight, smell, feel and unusual
More informationCigna Drug and Biologic Coverage Policy
Cigna Drug and Biologic Coverage Policy Subject Hereditary Angioedema (HAE) Therapy Table of Contents Coverage Policy... 1 General Background... 4 Coding/Billing Information... 7 References... 7 Effective
More informationCONTROL OF EXTERNAL BLEEDING
CONTROL OF EXTERNAL BLEEDING Responsibility Never hesitate to call 911 Life Safety is most important! It is the responsibility of every individual to learn to recognize the warning signs of a medical emergency.
More informationFUNDAMENTAL CRITERIA FOR FIRST AID INTRODUCTION
CHAPTER 1 FUNDAMENTAL CRITERIA FOR FIRST AID INTRODUCTION Soldiers may have to depend upon their first aid knowledge and skills to save themselves or other soldiers. They may be able to save a life, prevent
More informationLSU SPIRIT SQUAD TRYOUT APPLICATION (Please Circle): Male / Female Cheerleading Tiger Girls Mascot
LSU Student ID# Include below check list: Transfer student or incoming freshman; copy of acceptance letter to LSU Copy of Insurance; all applicants must have health insurance Application Participant Medical
More informationUsing the Lifebox oximeter in the neonatal unit. Tutorial 1 the basics
Using the Lifebox oximeter in the neonatal unit Tutorial 1 the basics Lifebox 2014. 2011. All rights reserved The Lifebox Pulse Oximeter In this tutorial you will learn about: The function of a pulse oximeter
More informationNitrous Oxide Oxygen Administration Protocol July 2002
Nitrous Oxide Oxygen Administration Protocol July 2002 Preamble A patient s self-administration of a nitrous oxide-oxygen mixture can provide relief of acute pain, provided there are no contraindications
More informationDoc #: 1000-AD Revision: - HEAT/COLD STRESS AWARENESS POLICY. Author(s): Tammie Lavoie, John Dunlop
Doc #: 1000-AD-015-0018 Revision: - HEAT/COLD STRESS AWARENESS POLICY Author(s): Tammie Lavoie, John Dunlop TABLE OF CONTENTS REVISION HISTORY... 3 1.0 INTRODUCTION... 4 2.0 PROGRAM FOCUS... 4 3.0 HAZARDS
More informationPackage leaflet: Information to the user. Medicinsk Lustgas Air Liquide 100%, medicinal gas, liquefied. Nitrous oxide 100% (medicinal laughing gas)
Package leaflet: Information to the user Medicinsk Lustgas Air Liquide 100%, medicinal gas, liquefied Nitrous oxide 100% (medicinal laughing gas) Read all of this leaflet carefully before you start using
More informationSection 14: Equipment failure
Risks associated with your anaesthetic Section 14: Equipment failure Summary This leaflet describes the types of equipment used by anaesthetists. It gives information about the ways in which equipment
More informationCHAPTER 3: TAKING ACTION AND CARING FOR BREATHING EMERGENCIES Multiple Choice
CHAPTER 3: TAKING ACTION AND CARING FOR BREATHING EMERGENCIES Multiple Choice Circle the correct answer. 1. One of the first steps to follow in an emergency is a. Transporting the victim to the hospital.
More informationClient s Guide to Prenoxad Injection
Client s Guide to Prenoxad Injection When you or someone you represent has been prescribed Prenoxad Injection (naloxone hydrochloride 1mg/1ml solution for injection) Introduction The purpose of this booklet
More informationClinical Policy: Testosterone Reference Number: AZ.CP.PHAR.02 Effective Date: Last Review Date: Line of Business: Arizona Medicaid
Clinical Policy: Reference Number: AZ.CP.PHAR.02 Effective Date: 11.16.16 Last Review Date: 09.12.18 Line of Business: Arizona Medicaid Revision Log See Important Reminder at the end of this policy for
More informationFIRST AID GUIDE Dr. Michael Stachiw, Ph.D.
FIRST AID GUIDE Revised May 19, 2003 This first aid guide is provided as a set of general instructions in using the materials included in the average first aid kit. It should be noted that this guide is
More informationRECOMBINATE. [Antihemophilic Factor (Recombinant)] (For intravenous use only)
Website for more information: http://www.recombinate.com/ INSTRUCTIONS FOR USE RECOMBINATE [Antihemophilic Factor (Recombinant)] (For intravenous use only) Do not attempt to do an infusion to yourself
More informationIATA Guidance for airline health and safety staff on the medical response to Cabin Air Quality Events
IATA Guidance for airline health and safety staff on the medical response to Cabin Air Quality Events (Smoke, Fumes/odours) 1. Introduction Much controversy exists in relation to the potential health ramifications
More informationPPL 10 CPR & AED TRAINING & CERTIFICATION
PPL 10 CPR & AED TRAINING & CERTIFICATION Knowing CPR means knowing how to save lives. The ACT Foundation is working to set up the lifesaving CPR program in every Canadian high school, so that all youth
More informationGSK Medicine: Study Number: Title: Rationale: Phase: Study Period: Study Design: Centres: Indication: Treatment: Objectives:
The study listed may include approved and non-approved uses, formulations or treatment regimens. The results reported in any single study may not reflect the overall results obtained on studies of a product.
More informationLast night, as I rounded the corner of Burrows and College, my legs felt the
Last night, as I rounded the corner of Burrows and College, my legs felt the previous 7 miles, and with only ¼ mile left, my breathing was controlled, my blood was flowing, and my heart was pumping. Advances
More information